New research that was recently presented at the annual meeting of the American Academy of Allergy, Asthma and Immunology (AAAAI) suggests that certain patients with egg allergy treated with oral immunotherapy (OIT) tolerated egg 5 years later.
In the latest issue of Science Translational Medicine, researchers from the U.K. demonstrated positive results in the treatment of asthma with a new oral medication
Within the past week, a new generic for Advair Diskus has gained FDA approval. This medication is approved for patients 4 years and older for those with asthma as well as COPD.
In a recent study published in JAMA Network Open, researchers from Northwestern University Feinberg School of Medicine found that about 19% of the 40,000 adult respondents to a survey self-reported […]
A recent phase 3 trial on oral peanut immunotherapy suggests positive results and is one step closer to FDA approval. This study was recently published in The New England Journal […]
